All Posts Tagged With: "MHS"

(CVS) Management Churn at CVS Caremark

CVS Caremark Corporation (CVS) recently announced a change in top management. According to the company’s design, effective September 1, 2012, the present EVP and Chief Operating Officer of the Pharmacy Benefit Management (PBM) business,...

4Apr2012 | | Comments Off | Continued

(MHS) Medco Healh Analyst Reiterates Shares at Neutral

Recently, we reiterated our Neutral recommendation on Medco Health (MHS) with a target price of $74.00. During the fourth quarter of fiscal 2011, Medco reported adjusted EPS of $1.25, beating the Zacks Consensus Estimate of...

22Mar2012 | | Comments Off | Continued

(ESRX) Company News for March 12, 2012 – Corporate Summary

•    Starbucks Corporation (NASDAQ:SBUX) launched the latest espresso brewer and announced that the company will be selling single-cup coffee machines •    According to reports, the Federal Trade Commission will not obstruct the merger...

13Mar2012 | | Comments Off | Continued

(CVS) CVS Caremark Remains Neutral

Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $46.00. CVS reported adjusted EPS of 89 cents in the fourth quarter of 2011 in line with the Zacks Consensus Estimate...

2Mar2012 | | Comments Off | Continued

(CVS) CVS Caremark Corporation Ordered by FTC to Settle Claims

Recently CVS Caremark Corporation (CVS) was asked by the Federal Trade Commission (FTC) to pay $5 million to settle all claims related to the company’s misrepresentation of prices of certain Medicare Part D prescription...

13Jan2012 | | 0 comments | Continued

(WAG) Walgreens 2012 First Quarter Earnings Scorecard

Subsequent to the announcement of Walgreen’s (WAG) first quarter 2012 (ended November 30) results on December 21, 2011, majority of the analysts have reduced their estimates for the forthcoming period. Previous Quarter...

9Jan2012 | | 0 comments | Continued

(ATHN) Grading the Investment U Gurus 2011: Marc Lichtenfeld

by Marc Lichtenfeld, Investment U Senior Analyst Tuesday, December 20, 2011: Issue #1668 I’m excited when my kids bring home their report cards....

9Jan2012 | | 0 comments | Continued

(ESRX) Walgreen Braves Express Scripts Loss

The six-month dispute with Express Scripts (ESRX) took its toll on Walgreen’s (WAG) recently released first quarter fiscal 2012 results. The company’s bottom-line...

3Jan2012 | | 0 comments | Continued

(WAG) Walgreen Plans to Offset Express Scripts Loss

Walgreen (WAG) is commencing the New Year with efforts aimed at minimizing the impact of the non-renewal of the Express Scripts (ESRX) contract, which has just lapsed....

3Jan2012 | | 0 comments | Continued

(CVS) CVS Caremark Corporation to Attend Healthcare Conference

The leading provider of prescriptions and related health care services in the US, CVS Caremark Corporation (CVS) has decided to participate in the annual JP Morgan Healthcare Conference scheduled on January 10, 2012. The company will...

30Dec2011 | | 0 comments | Continued

(ATHN) Grading the Investment U Gurus 2011: Marc Lichtenfeld

by Marc Lichtenfeld, Investment U Senior Analyst Tuesday, December 20, 2011: Issue #1668 I’m excited when my kids bring home their report cards....

21Dec2011 | | 0 comments | Continued

(CVS) CVS Caremark Launches New Pharmacy Advisor Program

CVS Caremark (CVS) recently launched a new Pharmacy Advisor program to help treat chronic cardiovascular illness. The Pharmacy Advisor for chronic cardiovascular care will primarily focus on medication adherence for persistent...

14Nov2011 | | 0 comments | Continued

(MHS) Medco Analyst Maintains Shares at Neutral

Recently, we reiterated our Neutral recommendation on Medco Health (MHS) with a target price of $56.00. During the third quarter of fiscal 2011, Medco reported adjusted EPS of $1.07, beating the Zacks Consensus Estimate by 2...

12Nov2011 | | 0 comments | Continued

(CVS) CVS Caremark Posts a Strong Quarter

CVS Caremark (CVS) reported third quarter 2011 EPS of 65 cents, 8.3% up year over year. However, after excluding the impact of certain one-time items, adjusted EPS came in at 70 cents, surpassing the Zacks Consensus Estimate of 67...

6Nov2011 | | 0 comments | Continued

(ESRX) Express Scripts Quarterly Report Beats by a Penny

Express Scripts Inc.’s (ESRX) third quarter 2011 earnings of 79 cents per share (excluding special items) were a penny above the Zacks Consensus Estimate and 22% above the year-ago adjusted earnings of 65 cents per share. The jump...

26Oct2011 | | 0 comments | Continued

(MHS) Medco Health Solutions and United Drug Terminate Joint Venture

Following the termination of the pan-European joint venture between Medco Health Solutions (MHS) and Germany-based Celesio AG, Dublin-based United Drug Plc recently decided to exit from its UK homecare partnership with Medco. As...

20Oct2011 | | 0 comments | Continued

(FTC) Medco Health Solutions and Express Script Asked for More Information from Federal Trade Commission

Recently, Federal Trade Commission (FTC) requested both Medco Health Solutions (MHS) and Express Script (ESRX) to submit additional information regarding the pending...

12Sep2011 | | 0 comments | Continued

(CVS) CVS Caremark Analyst Maintains Shares at Neutral

Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $38.00. CVS reported an adjusted EPS of 65 cents in the second quarter of 2011, surpassing the Zacks Consensus Estimate...

11Sep2011 | | 0 comments | Continued

(ABC) AmerisourceBergen Analyst Reiterates Neutral on Shares

We recently reiterated our Neutral recommendation on AmerisourceBergen Corporation (ABC) with a target price of $40.00. Over the last several years, the company has been benefiting from the growth of the pharmaceutical industry...

26Aug2011 | | 0 comments | Continued

(BIOS) BioScrip Analyst Maintains Neutral Rating on Shares

We maintain our Neutral recommendation on BioScrip Inc. (BIOS) with a target price of $6.25. BioScrip reported a loss of 4 cents per share in the second quarter of fiscal 2011 compared with the year-ago quarter EPS of 6 cents....

16Aug2011 | | 0 comments | Continued

(CVS) CVS Caremark Beats Earnings by a Penny – Guidance Narrowed

CVS Caremark (CVS) reported second quarter 2011 EPS of 60 cents, at par with the year-ago quarter earnings. However, after excluding the impact of certain one-time items, adjusted earnings per share came in at 65 cents, surpassing...

5Aug2011 | | 0 comments | Continued

(ESRX) Express Scripts Revenue Rises – Earnings Report In Line

Express Scripts Inc.’s (ESRX) second quarter 2011 earnings of 71 cents per share (excluding special items) were in line with the Zacks Consensus Estimate but were well above the year-ago adjusted earnings of 60 cents per share....

4Aug2011 | | 0 comments | Continued

(MHS) Express Scripts to Buy Medco Health Solutions

Following the release of its second quarter of fiscal 2011 earnings, Medco Health Solutions (MHS) announced that it will be acquired by Express Scripts (ESRX) for...

4Aug2011 | | 0 comments | Continued

(BT) Company News for July 22, 2011 – Corporate Summary

•    BB&T Corp. (NYSE:BBT) reported Q2 EPS of $0.44, slightly above the Zacks Consensus Estimate of $0.42 per share. Revenues rose 7% year-over-year to $2.18 billion, beating the Zacks Consensus Estimate of $2.148 billion •   ...

22Jul2011 | | 0 comments | Continued

(BT) Company News for July 22, 2011 – Corporate Summary

•    BB&T Corp. (NYSE:BBT) reported Q2 EPS of $0.44, slightly above the Zacks Consensus Estimate of $0.42 per share. Revenues rose 7% year-over-year to $2.18 billion, beating the Zacks Consensus Estimate of $2.148 billion •   ...

22Jul2011 | | 0 comments | Continued

(MHS) Medco Health Solutions 2011 Second Quarter Earnings Preview

Medco Health Solutions Inc. (MHS) is scheduled to release its second-quarter 2011 earnings on July 21, 2011 before the market opens. The company is expected to report EPS of 94 cents on revenues of...

20Jul2011 | | 0 comments | Continued

(AAPL) 2011 Second Quarter Earnings Preview – Detailed

Earnings Preview 7/15/11 Second quarter earnings season is now under way, but things really start to move into high gear next week. There will be 348 firms reporting, and 108 of those are in the S&P 500. By next...

18Jul2011 | | 0 comments | Continued

(CVS) CVS Caremark Corporation Study to Lower Treatment Costs

The leading provider of prescriptions and related health care services in the US, CVS Caremark Corporation (CVS) along with researchers from Harvard and Brigham universities and Women’s Hospital recently stated...

8Jul2011 | | 0 comments | Continued

(MHS) Medco Health Solutions to Better Tackle Hepatitis C

Medco Health Solutions (MHS) is making attempts to curtail costs of treating patients suffering from hepatitis C (HCV). The company’s specialty pharmacy segment, Accredo Health Group, considers patient adherence to the treatment...

6Jul2011 | | 0 comments | Continued

(MHS) Medco Health Solutions Aids Sanofi-Aventis Study

Medco Health Solutions (MHS) and its subsidiary United BioSource Corporation (UBC) have entered into a multi-year agreement with leading pharmaceutical company Sanofi-Aventis (SNY)....

28Jun2011 | | 0 comments | Continued